| Company Name: |
Biolab Reagents |
| Tel: |
027-65279366 18108604356 |
| Email: |
products@biolabreagent.com |
|
| | Acapatamab Basic information |
| Product Name: | Acapatamab | | Synonyms: | Acapatamab;Research Grade Acapatamab (DHG01305);Research Grade Acapatamab | | CAS: | 2314491-93-3 | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![Acapatamab Structure]() |
| | Acapatamab Chemical Properties |
| form | Liquid | | color | Colorless to light yellow |
| | Acapatamab Usage And Synthesis |
| Uses | Acapatamab (AMG-160) is an anti-CD3E/FOLH1 monoclonal antibody[1]. | | in vivo | Acapatamab (0.02-2 mg/kg; i.v.; days 16, 23, and 31) has antitumor activity and inhibits tumor growth in NOD/SCID mice with 22Rv-1 CRPC xenografts[1]. | Animal Model: | NOD/SCID mice with 22Rv-1 CRPC xenografts[1] | | Dosage: | 0.02, 0.2, and 2 mg/kg | | Administration: | Intravenous injection (days 16, 23, and 31) | | Result: | Had antitumor activity against established CRPC tumors. |
| | References | [1] Acapatamab |
| | Acapatamab Preparation Products And Raw materials |
|